217 related articles for article (PubMed ID: 1436266)
1. Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity.
Wolffenbuttel BH; Menheere PP; Nijst L; Rondas-Colbers GJ; Sels JP; Nieuwenhuijzen Kruseman AC
Neth J Med; 1992 Jun; 40(5-6):277-82. PubMed ID: 1436266
[TBL] [Abstract][Full Text] [Related]
2. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
3. Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents.
Del Prato S; Vigili de Kreutzenberg S; Riccio A; Maifreni L; Duner E; Lisato G; Iavicoli M; Tiengo A
Diabetologia; 1990 Nov; 33(11):688-95. PubMed ID: 2127573
[TBL] [Abstract][Full Text] [Related]
4. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
5. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
6. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
Banerji MA
J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():493-501. PubMed ID: 12017222
[TBL] [Abstract][Full Text] [Related]
7. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of pancreatic beta-cell secretion in Type 2 diabetic patients treated with gliclazide and glibenclamide.
van der Wal PS; Heine RJ
Diabetes Res Clin Pract; 2001 May; 52(2):103-11. PubMed ID: 11311964
[TBL] [Abstract][Full Text] [Related]
9. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
Willms B; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Nauck MA
J Clin Endocrinol Metab; 1996 Jan; 81(1):327-32. PubMed ID: 8550773
[TBL] [Abstract][Full Text] [Related]
10. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
Ahrén B; Larsson H; Holst JJ
J Clin Endocrinol Metab; 1997 Feb; 82(2):473-8. PubMed ID: 9024239
[TBL] [Abstract][Full Text] [Related]
12. [Insulin resistance and insulin secretion in type II non-obese diabetics].
Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
[TBL] [Abstract][Full Text] [Related]
13. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
[TBL] [Abstract][Full Text] [Related]
14. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in Type 2 diabetes.
Taverna MJ; Pacher N; Bruzzo F; Slama G; Selam JL
Diabet Med; 2001 Jul; 18(7):584-8. PubMed ID: 11553190
[TBL] [Abstract][Full Text] [Related]
16. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
Prigeon RL; Jacobson RK; Porte D; Kahn SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide improves insulin secretion and metabolic control in lean type 2 diabetic patients with secondary failure to sulphonylureas.
Polo V; Saibene A; Pontiroli AE
Acta Diabetol; 1998 Apr; 35(1):61-4. PubMed ID: 9625292
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
[TBL] [Abstract][Full Text] [Related]
19. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
20. Is type 2 diabetes a different disease in obese and nonobese patients?
Prando R; Cheli V; Melga P; Giusti R; Ciuchi E; Odetti P
Diabetes Care; 1998 Oct; 21(10):1680-5. PubMed ID: 9773730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
